Sharon Bio-Medicine intimates of USFDA inspection at its Dehradun formulations plant

Image
Capital Market
Last Updated : Aug 18 2015 | 5:47 PM IST

Second plant to be inspected in last 2 months

Sharon Bio-Medicine announced that the Company's Formulation Plant at Dehradun in Uttarakhand has been Inspected and Audited by USFDA officials.

This is the second plant which has been Inspected and Audited by USFDA officials in the last 2 months. First plant at Taloja near Navi Mumbai was Inspected and Audited in the first week of July 2015.

Powered by Capital Market - Live News

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 18 2015 | 3:14 PM IST

Next Story